Lifecore Biomedical Inc (LFCR)
5.87
+0.10
(+1.73%)
USD |
NASDAQ |
May 17, 16:00
5.85
-0.02
(-0.34%)
After-Hours: 20:00
Lifecore Biomedical Free Cash Flow (Quarterly)
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2023 | -9.435M |
| February 28, 2023 | -18.82M |
| November 30, 2022 | -6.201M |
| August 31, 2022 | -4.462M |
| May 31, 2022 | -11.95M |
| February 28, 2022 | -23.27M |
| November 30, 2021 | -10.23M |
| August 31, 2021 | -7.082M |
| May 31, 2021 | -7.969M |
| February 28, 2021 | -11.83M |
| November 30, 2020 | -1.349M |
| August 31, 2020 | 12.40M |
| May 31, 2020 | -17.27M |
| February 29, 2020 | 4.495M |
| November 30, 2019 | -15.53M |
| August 31, 2019 | -15.42M |
| May 31, 2019 | -13.02M |
| February 28, 2019 | -1.91M |
| November 30, 2018 | -1.531M |
| August 31, 2018 | -12.25M |
| May 31, 2018 | -13.38M |
| February 28, 2018 | 2.666M |
| November 30, 2017 | -0.824M |
| August 31, 2017 | -2.277M |
| May 31, 2017 | -6.858M |
| Date | Value |
|---|---|
| February 28, 2017 | 12.90M |
| November 30, 2016 | -3.547M |
| August 31, 2016 | 4.336M |
| May 31, 2016 | 0.796M |
| February 29, 2016 | -6.808M |
| November 30, 2015 | -7.669M |
| August 31, 2015 | -5.252M |
| May 31, 2015 | 5.933M |
| February 28, 2015 | 6.959M |
| November 30, 2014 | -3.63M |
| August 31, 2014 | -0.155M |
| May 31, 2014 | 2.517M |
| February 28, 2014 | 7.03M |
| November 30, 2013 | -3.581M |
| August 31, 2013 | 0.193M |
| May 31, 2013 | 3.416M |
| February 28, 2013 | 9.833M |
| November 30, 2012 | -3.952M |
| August 31, 2012 | 3.056M |
| May 31, 2012 | 12.17M |
| February 29, 2012 | 8.427M |
| November 30, 2011 | -6.581M |
| August 31, 2011 | 2.797M |
| May 31, 2011 | 0.226M |
| February 28, 2011 | 8.941M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-23.27M
Minimum
Feb 2022
12.40M
Maximum
Aug 2020
-9.233M
Average
-10.23M
Median
Nov 2021
Free Cash Flow (Quarterly) Benchmarks
| Aquestive Therapeutics Inc | -10.41M |
| SELLAS Life Sciences Group Inc | -10.76M |
| ADMA Biologics Inc | -4.58M |
| Relmada Therapeutics Inc | -13.04M |
| Jaguar Health Inc | -7.047M |